Covalently crosslinked trimer of a macrocyclic peptide derived from Abeta(17-36) - (ORN)LCVFFCED(ORN)AII(2-nitrobenzylglycine)L(ORN)V
Controlling the Oligomerization State of A beta-Derived Peptides with Light.
0.1 M sodium acetate pH 4.5 0.2 M sodium chloride 28% 2-methyl-2,4-pentanediol 0.1 M potassium iodide
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
Amyloid, oligomer, Alzheimer's Disease, Abeta, NEUROPEPTIDE
binding site for residues IOD A 101 and IOD A 102
binding site for Di-peptide ORN B 1 and VAL B 16
binding site for Di-peptide ORN B 1 and CYS B 2
binding site for Di-peptide ASP B 8 and ORN B 9
binding site for Di-peptide ORN B 9 and ALA B 10
binding site for Di-peptide ILE B 12 and EZY B 13
binding site for Di-peptide EZY B 13 and LEU B 14
binding site for Di-peptide LEU B 14 and ORN B 15
binding site for Di-peptide ORN B 15 and VAL B 16
binding site for Di-peptide ORN C 1 and CYS C 2
binding site for Di-peptide ORN C 1 and VAL C 16
binding site for Di-peptide ASP C 8 and ORN C 9
binding site for Di-peptide ORN C 9 and ALA C 10
binding site for Di-peptide ILE C 12 and EZY C 13
binding site for Di-peptide EZY C 13 and LEU C 14
binding site for Di-peptide LEU C 14 and ORN C 15
binding site for Di-peptide ORN C 15 and VAL C 16